CS logo
small CS logo
Salt Lake Research

Salt Lake City, Utah, United States
Research institute in Millcreek, Utah
1255 E 3900 S, Millcreek, UT 84124

About Salt Lake Research


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
AstraZeneca
4
Mannkind Corporation
3
Abbott
2
Bavarian Nordic
2
FemmePharma Global Healthcare, Inc.
2
Janssen Research & Development, LLC
2
Lumara Health, Inc.
2
Repros Therapeutics Inc.
2
Actelion
1
BioDelivery Sciences International
1
Bristol-Myers Squibb
1
Total Rows: 20

Clinical Trials at Salt Lake Research


During the past decade, Salt Lake Research conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years112222000011110011002200Started TrialsCompleted Trails2017201820192020202120220123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus
2002-05-01
2003-08-01
Completed
734
Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure
2002-05-01
Completed
200
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin
2002-03-01
2003-06-01
Completed
336
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea
2002-02-01
2003-08-01
Completed
377
R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence
2002-02-01
Unknown status
Comparison Study of MDX-010 (CTLA-4) Alone and Combined With Docetaxel in the Treatment of Patients With Hormone Refractory Prostate Cancer
2002-11-01
2004-11-01
Completed
Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer
2003-03-01
2004-07-01
Completed
164
The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy
2003-04-01
2005-04-01
Completed
200

Rows per page:

1–31 of 31

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Salt Lake Research" #1 sponsor was "AstraZeneca" with 4 trials, followed by "Mannkind Corporation" with 3 trials sponsored, "Abbott" with 2 trials sponsored, "Bavarian Nordic" with 2 trials sponsored and "FemmePharma Global Healthcare, Inc." with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 20 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Salt Lake Research" #1 collaborator was "PRA Health Sciences" with 3 trials as a collaborator, "Hoosier Cancer Research Network" with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator, "Procter and Gamble" with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.
Created with Highcharts 11.1.0Top Leading SponsorsAstraZeneca: 4AstraZeneca: 4Mannkind Corporation: 3Mannkind Corporation: 3Abbott: 2Abbott: 2Bavarian Nordic: 2Bavarian Nordic: 2FemmePharma GlobalHealthcare, Inc.: 2FemmePharma GlobalHealthcare, Inc.: 2Janssen Research &Development, LLC: 2Janssen Research &Development, LLC: 2Lumara Health, Inc.: 2Lumara Health, Inc.: 2Repros Therapeutics Inc.: 2Repros Therapeutics Inc.: 2Actelion: 1Actelion: 1BioDelivery SciencesInternational: 1BioDelivery SciencesInternational: 1

Created with Highcharts 11.1.0Top CollaboratorsPRA Health Sciences: 3PRA Health Sciences: 3Hoosier CancerResearch Network: 1Hoosier CancerResearch Network: 1National Cancer Institute (NCI): 1National Cancer Institute (NCI): 1Procter and Gamble: 1Procter and Gamble: 1Sanofi: 1Sanofi: 1Therion Biologics Corporation: 1Therion Biologics Corporation: 1Walther Cancer Institute: 1Walther Cancer Institute: 1

Clinical Trials Conditions at Salt Lake Research


According to Clinical.Site data, the most researched conditions in "Salt Lake Research" are "Prostate Cancer" (4 trials), "Healthy" (3 trials), "Diabetes Mellitus, Non-Insulin-Dependent" (2 trials), "Prostatic Neoplasms" (2 trials) and "Secondary Hypogonadism" (2 trials). Many other conditions were trialed in "Salt Lake Research" in a lesser frequency.

Clinical Trials Intervention Types at Salt Lake Research


Most popular intervention types in "Salt Lake Research" are "Drug" (29 trials), "Biological" (3 trials), "Other" (2 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (11 trials), "AC2993" (4 trials), "Androxal" (2 trials), "40 mg MSB11022" (1 trials) and "70% insulin aspart protamine suspension and 30% insulin aspart injection (rDNA origin)" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Salt Lake Research


The vast majority of trials in "Salt Lake Research" are 16 trials for "All" genders, 10 trials for "Male" genders and 5 trials for "Female" genders.

Clinical Trials Status at Salt Lake Research


Currently, there are NaN active trials in "Salt Lake Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Salt Lake Research, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Salt Lake Research, 6 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 12Phase 3: 12Phase 2: 8Phase 2: 8Phase 1: 6Phase 1: 6Phase 4: 2Phase 4: 2Not Applicable: 1Not Applicable: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 28Completed: 28Terminated: 2Terminated: 2Unknown status: 1Unknown status: 1